Back to JONES FINANCIAL COMPANIES LLLP JONES FINANCIAL COMPANIES LLLP

SLXNSLXN
3 quarters

Position history for JONES FINANCIAL COMPANIES LLLPJONES FINANCIAL COMPANIES LLLP's holdings in SILEXION THERAPEUTICS CORP

JONES FINANCIAL COMPANIES LLLP previously held 0 shares of SLXN (SILEXION THERAPEUTICS CORP), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$50

Total Shares Change

-26

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$2.55
0
2026-Q1
Unchanged
26
0.0%
$320.0%$1.66
0
2025-Q4
New
26
-
$500.0%$1.73
17

Other major holders of SLXN: CITADEL ADVISORS LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used